PIDD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PIDD Antibodies for understanding P53-induced protein with a death domain (PIDD) in cellular processes. PIDD Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PIDD plays a vital role in mediating apoptosis and regulating cellular response to stress, making it a significant target in cancer research and therapeutic development. The involvement of PIDD in caspase activation highlights its importance in programmed cell death, which maintains cellular homeostasis. Research has shown that PIDD functions as a molecular switch between cell survival and death pathways. Understanding PIDD mechanisms can reveal new insights into cancer development and potential treatment approaches. Investigating PIDD signaling pathways may lead to breakthroughs in understanding cellular stress responses. PIDD research continues to uncover new aspects of cell death regulation and survival mechanisms. Santa Cruz Biotechnology monoclonal antibodies for PIDD support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.